Alimera Sciences Inc (NASDAQ:ALIM)
| 4.42 Data as of May 21 |  +0.04 / +0.91%Today’s Change | 1.26 Today|||52-Week Range 5.10 | +181.53% Year-to-Date |
Latest ALIM News | Press Releases
No recent news for Alimera Sciences Inc.
Today’s Trading
| Previous close | 4.38 |
| Today’s open | 4.23 |
| Day’s range | 4.22 - 4.45 |
| Volume | 70,344 |
| Average volume (3 months) | 68,061 |
| Market cap | $138.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | +12.50% |
| Earnings growth (this year) | -33.92% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 19.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENZNEnzon Pharmaceutical... | +0.01 | +0.32% |
| KBIOKaloBios Pharmaceuti... | +0.05 | +0.86% |
| PTXPernix Therapeutics ... | -0.04 | -1.13% |
| GENTGentium SpA | +0.06 | +0.68% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$19.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Charles Daniel Myers |
Secretary, Chief Operating & Financial Officer Richard S. Eiswirth, Jr., CPA |
Corporate headquarters Alpharetta, Georgia |
Forecasts
